12/11/2007 00:00:00
UK: GW says cannabis pain drug passes clinical trial
---
Britain's GW Pharmaceuticals (GWP.L: Quote, Profile , Research) said on
Monday a clinical trial had shown its pionneering cannabis-based drug
Sativex was successful in treating neuropathic pain.
GW said The International Association of the Study of Pain had published
online the results of a study in its official journal, Pain. (Reporting
by Mark Potter; Editing by Quentin Bryar)
Source:
http://www.ukcia.org/news/shownewsarticle.php?articleid=13004
Author:
Reuters via UKCIA
|